Bentham Science Logo

Current Pharmaceutical Biotechnology

Volume 20, 15 Issues, 2019
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access

Ranking and Category

  • 259th of 298 in

    Biochemistry & Molecular Biology

  • 219th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print


Current Pharmaceutical Biotechnology, Volume 13 - Number 9

Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses

, 13(9): 1742 - 1749

Emma Borrego-Diaz, Rajesh Mathew, Dana Hawkinson, Tuba Esfandyari, Zhengian Liu, Patrick W Lee and Faris Farassati

DOI: 10.2174/138920112800958788

Oncolytic Viruses for Induction of Anti-Tumor Immunity

, 13(9): 1750 - 1760

Alex W. Tong, Neil Senzer, Vincenzo Cerullo, Nancy Smyth Templeton, Akseli Hemminki and John Nemunaitis

DOI: 10.2174/138920112800958913

The Molecular Basis of Herpesviruses as Oncolytic Agents

, 13(9): 1795 - 1803

Laura Menotti, Gabriella Campadelli-Fiume, Patrizia Nanni, Pier Luigi Lollini and Carla De Giovanni

DOI: 10.2174/138920112800958931

Recent Clinical Experience with Oncolytic Viruses

, 13(9): 1834 - 1841

O. G. Donnelly, F. Errington-Mais, R. Prestwich, K. Harrington, H. Pandha, R. Vile and A. A. Melcher

DOI: 10.2174/138920112800958904


Davide Prosperi
Department of Biotechnology and Bioscience
University of Milano-Bicocca

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Davide Prosperi serves as the Editor-in-Chief of the journal.
Track Your Manuscript:

Scopus CiteScore Metrics: 1.41

Related Journals

Related eBooks

eBooks Catalog